Credentis and DentaQuest Partner to Bring Innovative Cavity Prevention Products to US Markets

BOSTON–(BUSINESS WIRE)–credentis, a leader in state-of-the-art oral biology research and
development, and DentaQuest, the nation’s leading purpose-driven oral
health care organization, have entered into a strategic partnership to
test and promote Curodont™ Repair Fluoride Plus and other Curolox®
products in the North American Market, enabling better pre-cavity
treatment and prevention for US consumers. Through this collaboration,
DentaQuest will be the only US dental benefits company introducing these
innovative products through DentaQuest’s national caries management
partners and through its own preventive oral health centers.

As part of its Preventistry® platform, DentaQuest Impact Inc. invests in
innovative companies, technologies and products that have the potential
to revolutionize oral health for everyone by redefining prevention and
care. “In addition to giving Americans access to therapies that can
promote the healing of teeth and reverse the progression of tooth decay
before cavities form, we are excited to work with credentis to assess
the preventive benefits of their existing products and help develop new
ones that could help millions more live cavity free,” said Kirill
Zaydenman, Vice President of Innovation for DentaQuest. “We believe
credentis’ unique preventive technology has the potential to not only
improve consumer health and enhance patient experience, but also lower
the cost of care.”

“The partnership with DentaQuest provides an exceptional opportunity to
demonstrate the benefit of credentis’ Curolox products – in particular
the Guided Enamel Remineralization Therapy with Curodont Repair Fluoride
Plus – and establish them in US dental practice,” said Dominik Lysek,
CEO and founder of credentis ag.

This is the first investment of its kind for DentaQuest. According to
Alison Corcoran, President of DentaQuest Impact Inc., “We have a long
history of investing in oral health programs and research through the
DentaQuest Partnership for Oral Health Advancement, and our support has
helped drive positive change across the country for more than a decade,
but this is different. To truly transform oral health, we need to also
be partnering with – and investing in – many types of organizations, and
we are thrilled to welcome credentis to the Preventistry^® revolution.”

About DentaQuest
DentaQuest is a purpose-driven oral health
care company that is dedicated to advancing oral health for all. We
bring a uniquely holistic perspective to our work – as we manage dental
and vision benefits for more than 27 million Americans and provide
direct care to patients through our network of more than 85 oral health
centers in five states. DentaQuest provides flexible and customized
dental solutions for Medicaid and CHIP, Medicare Advantage, small and
large businesses and individuals throughout the U.S. Our clients range
from state governments to leading health plans. At DentaQuest, we
believe that business performance and social impact go hand-in-hand, and
we have provided more than $200 million in funding for research, grants,
and programs to advance oral health in communities across the country.
Our mission is bold – our commitment is strong. By advancing oral health
for everyone, we will achieve better health for all. Welcome to
Preventistry.

To learn more about DentaQuest and Preventistry, visit Preventistry.org,
and follow us on social: Twitter @DentaQuest,
Facebook www.facebook.com/DentaQuest,
Instagram @Inside_DentaQuest, and
LinkedIn www.linkedin.com/company/DentaQuest.

About credentis
credentis ag is headquartered in
Switzerland. credentis has won multiple awards as well as multiple
public grants include Swiss National Science Foundation (SNF), Aargauer
Forschungsfonds, CTI, and the Medical Technologies IKC.

Dr. Dominik Lysek, CEO and Michael Hug, CTO have a strong track record
in science, development and medical technology, with focus in the dental
industry. credentis board members Dr. Werner Berner, Dr. Michael Peetz,
Gerard Moufflet and Dr. Erich Platzer (chairman) contribute their
pharma, medtech and dental industry expertise.

About Curodont™ and the Curolox®
The patented CUROLOX® is
based on peptides self-assembling into a 3-dimensional matrix,
triggering biomimetic mineralisation and repair from calcium, phosphate
and fluoride. CUROLOX™ is the basis for all innovative credentis
products. With its CURODONT™ product line, credentis supports the
trend towards prevention and early treatment.
CURODONT™ REPAIR
& CURODONT™ REPAIR FLUORIDE PLUS provide dentists with a
non-invasive option for natural in-depth mineralisation or Guided Enamel
Remineralization (GER) which enables the regeneration of caries lesions
and similar defects.
CURODONT™ PROTECT uses CUROLOX® to
protect the tooth surface from acid attack.
CURODONT™ D’SENZ
is optimised for the treatment of dentine hypersensitivity, to be used
before dental hygiene treatment or in conjunction with tooth bleaching.

To learn more about credentis, Curodont and Curolox, visit credentis.com,
Curodont.us,
and follow us on social: Facebook
and LinkedIn

Contacts

Tom O’Rourke, Head of Corporate Communications
Thomas.orourke@greatdentalplans.com
(617)
886-1411